Ohki Healthcare Holdings Co.,Ltd. announced that it has received ¥1.2887 billion in funding from a group of investors
March 25, 2014
Share
Ohki Co., Ltd. (JASDAQ:8120) announced a private placement of 1,500,000 common shares and 1,130,000 treasury shares at ¥490 per share for gross proceeds of ¥1,288,700,000 on March 6, 2014. The shares will be issued by third party allotment. The transaction will include participation from a total of 26 investors including, Kokubu & Co., Ltd., which will invest for 1,000,000 shares, Takeda Pharmaceutical Co., Ltd., which will invest for 400,000 shares, and Asahi Food & Healthcare Co., Ltd., Pokka Sapporo Food & Beverage, Ltd., Kobayashi Pharmaceutical Co., Ltd., Hisamitsu Pharmaceutical Co., Inc., Earth Chemical Co., Ltd., and Meiji Co., Ltd., which will invest for 100,000 shares each among others. Kokubu & Co., Ltd. will hold 7.10% stake in the company after the transaction. The company will receive net proceeds of ¥1,276,700,000 after deducting various issue costs of ¥12,000,000. The board of the company approved the transaction. The settlement date and disposal date is March 26, 2014.
On March 26, 2014, Ohki Co., Ltd. closed the transaction.
OHKI HEALTHCARE HOLDINGS CO., LTD. is a Japan-based company mainly engaged in the management of its subsidiaries and the related businesses. The Company operates the production and sales of pharmaceutical products segment. The Company provides various products, such as pharmaceutical products, health food, health care products, nursing care products, oral products, baby products, daily necessities and clothing, confectionery, food, cosmetics and others.